Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal CancerJNCI CANCER SPECTRUMIF4.12022-01-102OAAI
Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systemsINTERNATIONAL JOURNAL OF CANCERIF4.72019-01-202OAAI
Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative IntentCLINICAL COLORECTAL CANCERIF3.22016-09-018PREAI
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon CancerCLINICAL CANCER RESEARCHIF10.22016-07-1425OAAI
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteriaINTERNATIONAL JOURNAL OF CANCERIF4.72015-09-0264OA
Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved SurvivalCLINICAL COLORECTAL CANCERIF3.22015-09-0153PREAI
Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAFV600E mutation优化靶向治疗开发: 对BRAFV600E突变的结直肠癌患者人群的分析INTERNATIONAL JOURNAL OF CANCERIF4.72011-03-08202OAAI
APER Rate Has Multiple Limitations as an Indicator of Quality in Rectal Cancer SurgeryANNALS OF SURGERYIF6.42008-12-015PREAI
Type 2 diabetes mellitus, smoking, and colorectal cancerAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62007-04-013PREAI
Preoperative radiotherapy for rectal cancerJOURNAL OF THE ROYAL SOCIETY OF MEDICINEIF7.12004-07-010OAAI